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Cyclic stretch-induced cPLA2 mediates ERK 1/2 signaling
in rabbit proximal tubule cells
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Cyclic stretch-induced cPLA2 mediates ERK 1/2 signaling in
rabbit proximal tubule cells.
Background. Recent evidence from this laboratory have
demonstrated a critical role of phospholipase A2 (PLA2) and
arachidonic acid in angiotensin II type 2 (AT2) receptor-
mediated kinase activation in renal epithelium independent of
phosphoinositide- specific phospholipase C (PLC) and without
the necessity of eicosanoid biosynthesis. In the present study,
we investigated whether cyclic stress phosphorylates and acti-
vates the mitogen-activated protein kinase (MAPK) pathway
and whether PLA2 activation mediates mechanotransduction in
renal epithelial cells. The rational for studying kidney epithelial
cells relates to their similarity to podocytes, which undergo me-
chanical stretch related to changes in intraglomerular pressure.
Methods. To produce strain or stretch, primary cultures of
rabbit proximal tubular cell cells are grown in tissue culture
wells having a collagen-coated Silastic deformable membrane
bottoms and applying vacuum to the well to generate alternating
cycles of stretch and relaxation (30 cycles/min).
Results. We found that cyclic stretching of rabbit proximal
tubular cells caused a time- and intensity-dependent activa-
tion of extracellular signal-regulated kinases 1 and 2 (ERK
1/2) in proximal tubular cells as detected by its phosphoryla-
tion. In addition, mechanical stretch induced PLA2 activation
and a subsequent rapid release of arachidonic acid. Inhibition
of PLA2 by mepacrine and methyl arachidonyl fluorophospho-
nate ketone (AACOCF3) attenuated both arachidonic acid re-
lease and ERK 1/2 activation by cyclic stretch, supporting the
importance of PLA2 as a mediator of mechanotransduction in
renal proximal tubular cells. A requirement for extracellular
Ca2+ and stretch-activated Ca2+ channels was also documented.
Complete inhibition of ERK 1/2 by PD98059, a MAPK kinase
(MEK) inhibitor, did not suppress stretch- induced PLA2 acti-
vation and arachidonic acid release, suggesting the later events
were upstream of ERK 1/2. Cyclic stretch also caused rapid
phosphorylation of the EGF receptor kinase and c-Src. Further-
more, arachidonic acid itself induced time- and dose-dependent
phosphorylation of c-Src. In addition, the c-Src inhibitor PP2
and selective EGF receptor kinase inhibitor AG1478 attenu-
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ated both ERK 1/2 and EGF receptor phosphorylation by cyclic
stretch.
Conclusion. PLA2 dependence for ERK 1/2 activation in re-
sponse to cyclic stretch in proximal tubular epithelial cells was
established in this report. In addition, these findings indicate
cyclic stretch increased the tyrosine phosphorylation of the EGF
receptor and c-Src and that c-Src acts upstream of the EGF re-
ceptor to mediate its phosphorylation, whereby both are criti-
cal for stretch- induced ERK 1/2 activation in rabbit proximal
tubular cells. These observations documents for the first time a
mechanism of mechanical stretch-induced kinase activation me-
diated by stretch activated Ca2+ channels and PLA2-dependent
release of arachidonic acid.
Shear stress and cyclic strain, physical forces known
to accompany hemodynamic alterations, trigger a vari-
ety of biochemical and architectural changes in renal
cell structure and function. Moreover, because epithelial
cells line the proximal tubules in situ they are contin-
ually exposed to shear stress and cyclic strain at their
apical surface. The physiologic responses to increased
shear stress and cyclic strain include activation of a large
number of kinases, including the mitogen-activated pro-
tein (MAPK) family [1–5]. However, the mechanism of
MAPK [extracellular-related kinases 1 and 2 (ERK 1/2)]
activation differs. Stretch-induced activation of ERK1/2
was dependent on protein kinase C (PKC) and protein
tyrosine kinases in cardiac myocytes and in bovine aortic
endothelial cells [6, 7], but not in thoracic aorta vascular
smooth muscle cells (VSMCs) or in mesangial cells [8, 9].
An increment in intracellular Ca2+ via stretch-activated
ion channels is required in bovine aortic endothelial cells,
but not in cardiomyocytes and alveolar epithelial cells [6,
10, 11]. The response of podocytes (a glomerular epithe-
lial cell) to cyclic stretch is an increased formation of stress
fibers [12]. By analogy, fluid sheer stress has been docu-
mented to activate members of the MAPK superfamily
and induce membrane phospholipid metabolism, phos-
pholipase A2 (PLA2) activation, and prostacyclin pro-
duction in endothelial cells [13–16]. This is of relevance
since in kidney epithelial cells, angiotensin II- induced ac-
tivation of the MAPK superfamily has been documented
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to be mediated by arachidonic acid following activation
of an angiotensin II type 2 (AT2) receptor subtype and a
membrane-associated PLA2 [17, 18]. However, it is not
yet known how mechanical stretch affects the activity
of the MAPK cascade in renal tubular epithelial cells, a
model analogous to the podocytes glomerular epithelial
cells. But, given our understanding of the critical role of
arachidonic acid and/or its cytochrome P450-dependent
metabolites as initiators of signaling in epithelial cells, we
reasoned that mechanical stretch of epithelial cells might
activate PLA2 thereby releasing arachidonic acid, initiat-
ing signaling and MAPK phosphorylation and activation.
Therefore, the current studies were designed to ascer-
tain whether cyclic stretch stimulates ERK 1/2 in rabbit
proximal tubule cells and to determine whether PLA2
activation and arachidonic acid release were involved.
We report herein a critical role for PLA2 activation and
arachidonic acid (without the necessity of conversion to
ecosanoid metabolites) in signaling linked to the stretch-
induced ERK 1/2 activation in rabbit proximal tubular
epithelium through mobilization of extracellular Ca2+ via
stretch-activated channels that is dependent upon phos-
phorylation of the epidermal growth factor (EGF) recep-
tor and c-Src activation.
METHODS
Chemicals
Phosphorylation site-specific polyclonal antibodies for
ERK 1/2 (p44 MAPK/p42 MAPK), cytosolic PLA2
(cPLA2), EGF receptor and c-Src were from Cell Signal-
ing Technology (Beverly, MA, USA). Antirabbit (goat)
and antimouse (goat) peroxidase conjugate IgG, bisin-
dolylmaleide I, hydrochloride (GF 109203X), Go¨ 6976,
wortmannin, LY 294002, PD 98059, nifedipine, pertus-
sis toxin, cholera toxin, and PP2 were from Calbiochem-
Novabiochem, Corp. (La Jolla, CA, USA). Anti EGF
receptor and phosphotyrosine (PY20) mouse mono-
clonal antibody were from BD Transduction Laborato-
ries (San Diego, CA, USA). Arachidonic acid was from
ICN (Costa Mesa, CA, USA). Antirabbit and antimouse
IgG agarose beads, indomethacin, gadolinium (III) chlo-
ride and quinacrine dihydrochloride (mepacrine) were
from Sigma Chemical Co. (St. Louis, MO, USA).
17-octadecynoic acid (17-ODYA), arachidonyl fluo-
rophosphonate ketone (AACOCF3), bromoenol lactone
(BEL), and tryphostin AG 1478 were from Biomol (Ply-
mouth Meeting, PA, USA). Cell culture media and
additives were from Invitrogen (Grand Island, NY,
USA). [3H]-arachidonic acid was from American Radio-
labeled Chemicals, Inc. (St. Louis, MO, USA).
Cell culture
Primary cultures of rabbit kidney proximal convoluted
tubules were prepared by a modification of Romero et al
[19]. Each experimental study was conducted with a sin-
gle primary culture set prepared from two kidneys ob-
tained from a male New Zealand white rabbit (1.5 to
2.0 kg). Briefly, the kidneys were removed with ster-
ile technique and decapsulated. Each kidney was per-
fused with the renal artery, first with oxygenated Collin’s
medium containing 5 lg/mL bovine insulin, 5 lg/mL
human transferrin, 10% fetal bovine serum (FBS),
0.6 mg/mL NaHCO3, and 0.14 mg/mL MgSO4, and sub-
sequently with oxygenated Collin’s medium containing
5 lg/mL bovine insulin, 5 lg/mL human transferrin, 10%
FBS, 0.6 mg/mL NaHCO3, 0.14 mg/mL MgSO4, and
25 mmol/L ethyleneglycol tetraacetate (EGTA). The cor-
tex was removed and placed in a sterile Petri dish and
minced with scissors. The tissue was then homogenized in
oxygenated Collin’s medium containing 5 lg/mL bovine
insulin, 5 lg/mL human transferrin, 10% FBS, 0.6 mg/mL
NaHCO3, 0.14 mg/mL MgSO4, and 600 units of DNAse I
with several strokes of a sterile glass homogenizer (type
A pestle). Intact proximal tubule cells were collected by
serial sieving of cortical homogenate and centrifuged at
1400 rpm at 4◦C for 12 minutes. The pellet was resus-
pended and washed with Dulbecco’s modified Eagle’s
medium (DMEM)/F-12 medium containing 25 mmol/L
DNAse I and centrifuged at 1400 rpm at 4◦C for 12 min-
utes. The cells were then placed on a 30% to 60% dis-
continuous Percoll (Sigma Chemical Co.) gradient and
centrifuged at 25,000 rpm for 20 minutes at 4◦C. After
centrifugation, the cellular mixture separated into dis-
tinct bands. The proximal tubule cells were obtained from
the third band, washed, and centrifuged twice (1400 rpm
at 4◦C for 12 minutes) in fresh DMEM/F-12 medium
containing 25 mmol/L DNAse I, plated and maintained
in standard growth media, DMEM/F-12 supplemented
with 15 mmol/L Hepes buffer (pH 7.4), 0.35 mg/mL L-
glutamine, 0.6 mg/mL sodium bicarbonate, 100 U/mL
penicillin, 100 mg/mL streptomycin, 5 lg/mL bovine in-
sulin, 5 lg/mL human transferrin, 0.5 lmol/L hydrocor-
tisone, and 5% FBS. Cells were grown on 75 cm2 Costar
Petri dishes as subconfluent monolayers. The medium
was changed 1 day after plating and every 3 days there-
after. Proximal tubule cells were subsequently passaged
onto 100 mm tissue culture dishes or 6-well plates with
flexible bottoms coated with type I collagen (Flexcell In-
ternational, McKeesport, PA, USA). Tissue was analyzed
by light microscopy to confirm morphology and the ab-
sent of mesangial cells. Subconfluent (80% confluence)
cells were made quiescent by incubating in serum-free
standard growth medium for 48 hours (unless noted oth-
erwise) and subsequently subjected to cyclic stretch (30
cycles/minute; 30 cycles stretch and 30 cycles relaxation).
Stretch was mediated by controlled cycles of vacuum-
assisted system (Flexercell Strain Unit) (Flexcell Inter-
national). Vacuum pressure was applied to induce 2%
to 20% uniaxial elongation in the culture surface. Stretch
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and control experiments were carried out simultaneously
with cells derived from a single pool. Control cells were
grown in identical plates in parallel. All studies were per-
formed with first passages of primary cultures of rabbit
kidney proximal tubule cells.
Immunoprecipitation and Western blotting
For immunoprecipitation, cell lysates were extracted
with lysis buffer [50 mmol/L Tris-HCl (pH 7.6),
150 mmol/L NaCl, 0.5% sodium deoxycholate (wt/vol),
1% NP-40 (IGEPAL CA-630) (vol/vol), 1% Triton
X-100 (vol/vol), 1 mmol/L Na3VO4, 1 mmol/L EGTA,
0.2 mmol/L phenylmethanesulfonyl fluoride, 1 mmol/L
NaF, 25 lg/mL leupeptin, 10 lg/mL pepstatin, and 10 lg/
mL aprotinin] and were adjusted to an equal amount
of protein (1 mg) and equal volume. Designated anti-
body (IgG) was added, and samples were incubated at
4◦C overnight. Immune complexes were recovered by
the addition of 100 lL of antirabbit or antimouse IgG
agarose (Sigma Chemical Co.). Samples were incubated
for 2 hours with gentle agitation at 4◦C. The immuno-
precipitates were washed three times with lysis buffer.
The immunoprecipitated proteins were eluted with 50 lL
sodium dodecyl sulfate (SDS) sample buffer [60 mmol/L
Tris-HCl, 2% (wt/vol) SDS, and 5% (vol/vol) glycerol,
pH 6.8], boiled for 5 minutes and then subjected to
SDS-polyacrylamide gel electrophoresis (PAGE). The
proteins were then transferred to a polyvinylidene di-
flouride (PVD) membrane by electroblotting at 200 mA
for 11/2 hours. After electrophoresis, nonspecific bind-
ing was blocked by incubation with 5% (wt/vol) non-
fat milk in phosphate-buffered saline (PBS) containing
1% Tween-20 (PBS/T) for 60 minutes. Membranes were
immunoblotted with designated antibody. After a 24-
hour incubation at 4◦C, the membrane was washed three
times with PBS/T and incubated for 60 minutes at room
temperature with horseradish peroxidase-conjugated an-
timouse (goat) or antirabbit (goat) IgG (Calbiochem-
Novabiochem, Corp.). After washing, blots were devel-
oped with an enhanced chemiluminescence detection kit
from Amersham Pharmacia Biotech (Oakville, Ontario).
For direct western analysis of active ERK 1/2, c-Src,
EGF receptor, and cPLA2, rabbit proximal tubule cells
were lysed with cell lysis buffer (50 lL/well) and cen-
trifuged at 4◦C for 15 minutes. After boiling for 5 minutes,
samples (20 to 50 lg protein) were boiled in SDS sam-
ple buffer, subjected to SDS-PAGE, and immunoblotted
with designated antibodies as described above. Protein
contents were determined by BCA assay (Pierce Bio-
chemicals, Rockford, IL, USA).
Measurement of arachidonic acid release
Rabbit proximal tubule cells were plated on 6-well
plates with flexible bottoms coated with type I colla-
gen (Flexcell International) in standard growth medium,
grown to 90% confluence and subsequently serum re-
stricted for 24 hours. Serum-deprived proximal tubule
cells were exposed to inhibitors for indicated time pe-
riods. Aliquots of serum-free DMEM containing [3H]-
arachidonic acid (1 lCi/mL) was added and the cells
were incubated for 4 hours at 37◦C. The media was re-
moved and the cells were then washed three times with
2 mL of DMEM containing 0.1% fatty acid-free bovine
serum albumin (BSA) and then subjected to repeated me-
chanical stretch/relaxation cycles for indicated time peri-
ods. Appropriate control experiments were conducted in
parallel. At the end of each experiment, the incubation
medium was removed and transferred to ice-cold tubes.
The tubes were then centrifuged at 13,000 rpm for 5 min-
utes to eliminate cell debris. To determine the level of
radioactivity in the supernatant, 0.5 mL of each sample
was placed in a scintillation vial and the radioactivity in
the medium was quantified by liquid scintillation spec-
trometry (Beckman Coulter, Inc., Miami, FL, USA).
Statistics analysis
The results are expressed as means ± SEM from com-
bined experiments. The data were evaluated by one-way
analysis of variance (ANOVA) followed by Newman-
Keuls multiple comparison test or by paired t test when
appropriate. The limit of significance was a P value ≤
0.05.
RESULTS
Cyclic stretch activates ERK 1/2 in a time- and
intensity-dependent manner in rabbit proximal
tubule cells
We first investigated the time course of cyclic stretch-
dependent ERK 1/2 activation in primary cultured
rabbit proximal tubule cells. Cyclic stretch-induced time-
dependent activation of ERK 1/2 was detected by West-
ern blot with phospho-specific ERK 1/2 antibodies. ERK
1/2 activity was significant at 1 minute, with a maximum
effect at 15 minutes (Fig. 1A). In addition, cyclic stretch-
induced ERK 1/2 activity was found to be intensity
dependent. When exposed for 10 minutes to increasing
intensities of cyclic stretch (0% to 20% stretch), ERK 1/2
activation was significant at 5% stretch with a maximal
effect at 15% stretch (Fig. 1B). For subsequent studies,
cells were treated for 15 minutes at 15% stretch to detect
maximal ERK 1/2 activation, unless otherwise indicated.
Stretch-induced cPLA2 activation and [3H]-arachidonic
acid release
To assess whether cyclic stretch activates cPLA2 in
addition to eliciting ERK 1/2 activation, serum-starved
proximal tubular cells were exposed to cyclic stretch for
varying lengths of time (1 minute to 1 hour) followed by
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Fig. 1. Cyclic stretch induces extracellular-
regulated kinases 1 and 2 (ERK 1/2) phos-
phorylation in time- and intensity-dependent
manner in rabbit proximal tubule cells.
(A) Serum-starved proximal tubule epithe-
lial cells were either exposed to cyclic stretch
(30 cycles/minute; 15% stretch) for the in-
dicated times or (B) to various intensity of
cyclic stretch (2% to 20% stretch) for 15 min-
utes (30 cycles/minute). The cells were then
lysed and equal amounts of proteins were
subjected to immunoblot analysis with poly-
clonal antibodies that specifically recognizes
the phosphorylated forms of ERK 1 and ERK
2 (top panels). The same blot was stripped
and reprobed with control anti-ERK anti-
body showing equal loading and confirming
the signal detected with the phospho-antibody
(lower panels). Bar graphs represent inten-
sities of both phospho-ERK 1 and phospho
ERK 2 quantified by scanning densitometry of
blots and are expressed as a percentage rela-
tive to control. Data are mean ± SEM of three
independent experiments. Statistical compar-
isons were made with a one-way analysis of
variance (ANOVA) followed by Newman-
Keuls multiple comparisons test. ∗∗∗P < 0.001;
∗∗P < 0.01; ∗P < 0.05 with respect to un-
stretched cells.
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Fig. 2. Cyclic stretch induces rapid phos-
phorylation of cytoplasmic phospholipase A2
(cPLA2) in rabbit proximal tubule cells.
Serum-starved proximal tubule epithelial
cells were exposed to cyclic stretch (30 cy-
cles/minute, 15% stretch) for the indicated
times (A) or (B) to various intensity of cyclic
stretch (2% to 20% stretch) for 15 minutes
(30 cycles/minute). The cells were then lysed
and equal amounts of proteins were subjected
to immunoblot analysis with polyclonal anti-
bodies that specifically recognizes the phos-
phorylated form of cPLA2 (top panel). The
same blot was stripped and reprobed with
control anti-cPLA2 antibody showing equal
loading and confirming the signal detected
with the phospho-antibody (lower panels).
Bar graphs represent intensities of cPLA2
quantified by scanning densitometry of blots
and are expressed as a percentage relative
to control. Data are mean ± SEM of three
independent experiments. Statistical compar-
isons were made with a one-way analysis of
variance (ANOVA) followed by Newman-
Keuls multiple comparisons test. ∗∗∗P < 0.001;
∗∗P < 0.01 with respect to unstretched cells.
Western blot analysis with phospho-cPLA2 (Ser505) an-
tibody. The onset of cPLA2 activation was significant at
5 minutes and maximal at 15 minutes (Fig. 2A). The time
courses of ERK 1/2 and cPLA2 activation were similar,
suggesting the two processes may be interrelated. In ad-
dition, stretch-induced cPLA2 activation was found to be
intensity dependent and was significant at 5% elongation
with a maximal effect at 15% elongation (Fig. 2B).
In parallel studies, cyclic stretch-induced time-
dependent increase in arachidonic acid liberation from
[3H]-arachidonic acid-labeled cells. A significant increase
was observed within 5 minutes and reached a maxi-
mum at 15 minutes (Fig. 3A). An intensity-dependent
arachidonic acid release was observed when cells were
exposed to cyclic stretched (2% to 20% stretch) for
15 minutes. The increase arachidonic acid release was sig-
nificant at 2% stretch and maximum release was observed
at 15% stretch (Fig. 3B). Moreover, the mechanism of
arachidonic acid release and ERK 1/2 activation seems
to involve Ca2+-dependent cPLA2. Indeed, 50 lmol/L
mepacrine, a nonspecific PLA2 inhibitor, and 50 lmol/L
AACOCF3, a more specific Ca2+-dependent cPLA2
inhibitor, caused a 66% ± 13% and 64% ± 6% inhibi-
tion of cyclic stretch-induced arachidonic acid release,
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Fig. 3. Release of [3H]-arachidonic acid in rabbit proximal tubule cells
by cyclic stretch. Serum-starved rabbit proximal tubular epithelial cells
were prelabeled with [3H]-arachidonic acid (1 lCi/mL) for 4 hours as
described in the Methods section and then exposed to cyclic stretch
(30 cycles/minute; 15% stretch) for the indicated times (A) or to vari-
ous intensity of cyclic stretch (2% to 20% stretch) for 15 minutes (30
cycles/minute) (B). The radioactivity in the extracellular medium was
counted by liquid scintillation spectrometry. Data represent mean ±
SEM from at least four independent experiments performed in trip-
licate. Statistical comparisons were made with a one- way analysis of
variance (ANOVA) followed by Newman-Keuls multiple comparisons
test. In time response curve ∗∗∗P < 0.001; ∗∗P < 0.01; ∗P < 0.05 (with re-
spect to time-matched unstretched control cells). In intensity response
curve ∗∗∗P < 0.001; ∗∗P < 0.01; ∗P < 0.05 versus unstretched control
cells.
respectively, whereas pretreatment of proximal tubu-
lar cells with BEL, a Ca2+-independent PLA2 (iPLA2),
did not (Fig. 4A). Similarly, cyclic stretch-induced ERK
1/2 activation was sensitive to both mepacrine and AA-
COCF3, attenuating stretch-induced ERK 1/2 activity by
50% ± 7% and 40% ± 5%, respectively (Fig. 4B). In con-
trast, pretreatment of proximal tubular cells with BEL
had no significant effect on cyclic stretch-induced ERK
1/2 activation. There was no requirement for conversion
of arachidonic acid active metabolites since none of the
inhibitors attenuated cyclic stretch-induced ERK 1/2 ac-
tivation (data no shown).
To verify that MAPK was not upstream of PLA2,
we evaluated whether MAPK kinase (MEK) inhibition
would attenuate PLA2 activation. Complete inhibition of
ERK 1/2 by PD98059, a MEK inhibitor, did not suppress
cyclic stretch-induced cPLA2 activation or arachidonic
acid release (data not shown). These results demonstrate
a novel mechanism of cyclic stretch-induced ERK 1/2 ac-
tivation wherein PLA2 and arachidonic acid are upstream
of ERK 1/2 activation.
Stretch-induced [3H]-arachidonic acid release, cPLA2,
and ERK 1/2 activation are dependent of extracellular
Ca2+ and stretch-activated channels
To clarify the role of Ca2+ in cyclic stretch-induced
cPLA2 and ERK 1/2 activation, we applied the ex-
tracellular calcium chelator EGTA, the intracellular
calcium chelator BAPTA/AM and the voltage-gated
Ca2+channel blocker nifedipine. The data presented in
Figure 5A and B show that cyclic stretch caused more
than a threefold increase in both ERK 1/2 and cPLA2 ac-
tivation in proximal tubule cells. The removal of extracel-
lular Ca2+ caused an 84% and 86% reduction in the ERK
1/2 and cPLA2 response induced by cyclic stretch, respec-
tively. In contrast, there were no changes in levels of ERK
1/2 and cPLA2 activation following exposure to cyclic
stretch either presence of BAPTA/AM or nifedipine. In
addition, the mechanism of cyclic stretch-induced arachi-
donic acid release seems to involve a Ca2+-dependent
cPLA2 since the presence of 3 mmol/L EGTA strongly
reduced the cyclic stretch-induced arachidonic acid liber-
ation by 93%, whereas BAPTA/AM and nifedipine was
without effect (Fig. 5C). In addition, stretch-activated
channels appear to be involved since gadolinium (Gd3+)
blocked this process, whereas pharmacologic phospholi-
pase 3 (PI3) kinase inhibitors wortmannin and LY 294002
did not effect stretch-induced ERK 1/2 and cPLA2 ac-
tivation or arachidonic acid release (Fig. 6). Moreover,
Gd3+ alone had no effect on basal levels of arachidonic
acid release and cPLA2 and ERK 1/2 activation. This ef-
fect was not due to differences in angiotensin II receptor
expression because the stretch-induced arachidonic acid
release and ERK 1/2 activation was not inhibited by the
angiotensin AT1 receptor antagonists losartan and can-
desartan or by the angiotensin AT2 receptor antagonist
PD123319 (data not shown). Moreover, replacement of
medium with culture medium of stretched cells did not
caused arachidonic release or ERK 1/2 activation (data
not shown). Collectively, these studies suggest a Ca2+
dependence for cyclic stretch-induced cPLA2 activation,
arachidonic acid release, and ERK 1/2 activation medi-
ated via stretch-activated channels but independent of
angiotensin system or other autocoid.
Cyclic stretch-induced ERK 1/2 activation is mediated via
EGF receptor- and c-Src-dependent pathways
Exposure of proximal tubular cells to cyclic stretch
caused time- dependent increase in Tyr416 phosphoryla-
tion of c-Src that was evident early as 1 minute, maximum
at 15 minutes, and returned below basal by 60 minutes
(Fig. 7A). By comparison, cyclic stretching of proximal
tubular cells caused time-dependent increase in Tyr1068
phosphorylation of the EGF receptor that was observed
at 1 minute, maximal phosphorylation was achieved at
15 minutes after cyclic stretch (15% stretch), and re-
turned near basal by 60 minutes (Fig. 7B). Furthermore,
arachidonic acid itself induced time- and dose-dependent
phosphorylation of c-Src (Fig. 8). In addition, pretreat-
ment of proximal tubule cells with a potent Src fam-
ily kinase inhibitor, PP2, completely abolished the cyclic
stretch-induced EGF receptor and ERK 1/2 phosphory-
lation (Fig. 9A and C, respectively). However, there was
no measurable involvement of EGF receptor phospho-
rylation in c-Src activation following exposure to cyclic
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Fig. 4. Effects of phospholipase A2(PLA2) inhibitors on cyclic stretch-
induced [3H]-arachidonic acid release and extracellular-regulated ki-
nases 1 and 2 (ERK 1/2) phosphorylation. (A) Serum-starved proxi-
mal tubular cells were incubated with or without 50 lmol/L mepacrine,
50 lmol/L arachidonyl fluorophosphonate ketone (AACOCF3) or 10
lmol/L bromoenol lactone (BEL) for 30 minutes, prelabeled with [3H]-
arachidonic acid (1 lCi/mL) for 4 hours and then exposed to cyclic
stretch (30 cycles/minute; 15% stretch) for 15 minutes. The radioactiv-
ity in the extracellular medium was counted by liquid scintillation spec-
trometry. Data represent mean ± SEM from at least four independent
experiments performed in triplicate and are expressed as a percentage
relative to control. Statistical comparisons were made with a one-way
analysis of variance (ANOVA) followed by Newman-Keuls multiple
comparisons test. ∗∗∗P < 0.001 (stretch versus unstretched control);
stretch despite the fact that AG1478 blocked ERK 1/2
phosphorylation(Fig. 9B and C, respectively), consistent
with c-Src being upstream of these events.
DISCUSSION
While the influences of mechanical stress, such as fluid
shear stress and cyclic mechanical stretch have been
widely investigated in endothelium, it has been generally
under investigated as a mediator of epithelial cell func-
tion [6, 12, 16, 20]. Utilizing an in vitro model that induces
tissue strain or stretch, we have demonstrated that cyclic
stretch stimulates a rapid activation of cPLA2, arachi-
donic acid release and ERK 1/2 activation in primary cul-
tures of rabbit proximal tubule cells. These observations
are consistent with a sequence of events initiated by cyclic
stretch- induced activation of a channel, one of which is a
calcium (Ca2+) channel followed by phosphorylation of a
cPLA2 and arachidonic acid release. Subsequent events
involve activation of c-Src, phosphorylation of the EGF
receptor and ERK 1/2 activation. This represents a novel
signaling paradigm linked to cyclic stretch in the kidney
and other locations.
Agonist-induced arachidonic acid release in several
cell types is mediated by the Ca2+-sensitive 85 kD cPLA2,
whereby both arachidonic acid and cPLA2 are believed
to act as an important intracellular messenger to receptor
tyrosine kinase and MAPK phosphorylation and activa-
tion. Evidence in support of this includes the observa-
tions that exogenous arachidonic acid stimulates MAPK
in various cell types, including rabbit proximal tubular
epithelial cells [21–25]. By analogy, endothelial cells in
culture have been shown to respond to shear stress with
increase cPLA2 activity, arachidonic release, and the pro-
duction of prostacyclin [14, 15]. Although cPLA2 has
been implicated as an important signal-transducing com-
ponent in shear stress-mediated signaling, the function of
this lipid kinase in cyclic stretch-triggered events has re-
mained obscure. Furthermore, it is also proposed that
+++P < 0.001 (with respect to time- matched unstretched controls). (B)
Serum-starved proximal tubular cells were incubated with or without
50 lmol/L mepacrine, 50 lmol/L AACOCF3 or 10 lmol/L BEL for
30 minutes and then exposed to cyclic stretch (30 cycles/minute; 15%
stretch) for 15 minutes. The cells were then lysed and equal amounts of
proteins were subjected to immunoblot analysis with polyclonal anti-
bodies that specifically recognizes the phosphorylated forms of ERK 1
and ERK 2 (top panels). The same blot was stripped and reprobed with
control anti-ERK antibody showing equal loading and confirming the
signal detected with the phospho-antibody (lower panels). Bar graphs
represent intensities of both phosphor-ERK 1 and phosphor-ERK 2
quantified by scanning densitometry of blots and are expressed as a
percentage relative to control. Data are mean ± SEM of three inde-
pendent experiments. Statistical comparisons were made with a one-
way analysis of variance (ANOVA) followed by Newman-Keuls mul-
tiple comparisons test. ∗∗∗P < 0.001 (inhibitor + stretch versus stretch
alone).
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Fig. 5. Cyclic stretch-induced [3H]-arachidonic acid release, cytoplasmic phospholipase A2 (cPLA2) and extracellular-regulated kinases 1 and 2
(ERK 1/2) activation is dependent of extracellular Ca2+. Serum-starved proximal tubular cells were incubated with or without 3 mmol/L ethyleneg-
lycol tetraacetate (EGTA) for 5 minutes or with or without 50 lmol/L BAPTA/AM or 10 lmol/L nifedipine for 30 minutes and then exposed to
cyclic stretch (30 cycles/minute; 15% stretch) for 15 minutes. The cells were then lysed and equal amounts of proteins were subjected to immunoblot
analysis with polyclonal antibodies that specifically recognizes the phosphorylated forms of ERK 1 and ERK 2 (A) and cPLA2 (B) (top panels).
The same blot was stripped and reprobed with either a control anti-ERK or anti-cPLA2 antibody showing equal loading and confirming the signal
detected with the phospho-antibody (lower panels). Bar graphs represent intensities of both phosphor-ERK 1 and phosphor-ERK 2 or cPLA2
quantified by scanning densitometry of blots and are expressed as a percentage relative to control. Data are mean ± SEM of three independent
experiments. Statistical comparisons were made with a one-way analysis of variance (ANOVA) followed by Newman-Keuls multiple comparisons
test. ∗∗∗P < 0.001 versus unstretched cells; +++P < 0.001 (stretch versus stretch + inhibitor). (C) Serum-starved proximal tubular cells were incu-
bated with or without 3 mmol/L EGTA for 5 minutes or with or without 50 lmol/L BAPTA/AM or 10 lmol/L nifedipine for 30 minutes, labeled with
[3H]-arachidonic acid (1 lCi/mL) for 4 hours and then exposed to cyclic stretch (30 cycles/minute; 15% stretch) for 15 minutes. The radioactivity in
the extracellular medium was counted by liquid scintillation spectrometry. Data represent mean ± SEM from at least four independent experiments
performed in triplicate and are expressed as a percentage relative to control. Statistical comparisons were made with a one-way analysis of variance
(ANOVA) followed by Newman-Keuls multiple comparisons test. ∗∗∗P < 0.001 versus unstretched control; +++P < 0.001 (stretch versus stretch +
inhibitor).
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Fig. 7. Cyclic stretch induces c-Src and epidermal growth factor (EGF) receptor phosphorylation in rabbit proximal tubule cells. Serum-starved
proximal tubule epithelial cells were either exposed to cyclic stretch (30 cycles/minute; 15% stretch) for the indicated times. (A) Activation of
c-Src was evaluated by Western blot analysis using an anti-phosphorylated Src py416-specific antibody (upper panel). (B) EGF receptor was
immunoprecipitated (IP) from protein extracts (1 mg) using a anti-EGF receptor antibody and subsequently evaluated by Western blot analysis
using an anti- phosphorylated EGF receptor py1068-specific antibody (upper panel). The same blot was stripped and reprobed with control anti-c-Src
or anti-EGF receptor antibodies showing equal loading and confirming the signal detected with the phospho-antibody (lower panels). Bar graphs
represent intensities of phospho-c-Src and phospho-EGF receptor quantified by scanning densitometry of blots and are expressed as a percentage
relative to control. Data are mean ± SEM of three independent experiments. Statistical comparisons were made with a one- way analysis of variance
(ANOVA) followed by Newman-Keuls multiple comparisons test. ∗∗∗P < 0.001; ∗∗P < 0.01; ∗P < 0.05 with respect to unstretched cells.
there are MAPK-dependent and MAPK-independent
mechanisms for the activation of cPLA2 [26–30]. In
this study, we found that cPLA2 activation and arachi-
donic acid release were abrogated by the nonspecific
PLA2 activity inhibitor, mepacrine. In addition, pretreat-
ment of proximal tubular cells with arachidonyl trifluo-
romethyl ketone, AACOCF3, a more specific cytosolic
Ca2+-dependent cPLA2 inhibitor, also blocked stretch-
induced arachidonic acid release and ERK 1/2 activation.
Thus, the novel and key finding is that cPLA2 activation
and arachidonic acid release appear to be obligatory up-
stream mediators for the cyclic stretch-induced activation
of ERK 1/2. Conversely, ERK 1/2 activation does not ap-
pear to be necessary for stretch-induced cPLA2 activation
and arachidonic acid release as has been proposed in a
variety of other reports [30–33].
We explored the role of Ca2+ and Ca2+-dependent
steps leading to ERK 1/2 activation induced by cyclic
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 6. Cyclic stretch-induced [3H]-arachidonic acid release, cytoplasmic phospholipase A2 (cPLA2) activation and extracellular-regulated kinases
1 and 2 (ERK 1/2) phosphorylation is dependent of stretch-activated channels. Serum-starved proximal tubular cells were incubated with or without
100 nmol/L wortmannin, 25 lmol/L LY294002, or 50 lmol/L gadolinium (Gd3+) for 30 minutes and then exposed to cyclic stretch (30 cycles/minute;
15% stretch) for 15 minutes. The cells were then lysed and equal amounts of proteins were subjected to immunoblot analysis with polyclonal
antibody that specifically recognizes the phosphorylated forms of ERK 1 and ERK 2 (top panels). The same blot was stripped and reprobed
with control anti-ERK antibody showing equal loading and confirming the signal detected with the phospho-antibody (lower panels). Bar graphs
represent intensities of both phosphor-ERK 1 and phosphor-ERK 2 quantified by scanning densitometry of blots and are expressed as a percentage
relative to control. Data are mean ± SEM of three independent experiments. Statistical comparisons were made with a one-way analysis of variance
(ANOVA) followed by Newman-Keuls multiple comparisons test. ∗∗∗P < 0.001 versus unstretched control cells; +++P < 0.001 (stretch versus
stretch + inhibitor).
stretch and demonstrate that phosphorylation decreased
only after pretreatment with the extracellular Ca2+ chela-
tor EGTA, but not with BAPTA/AM, an intracellular
Ca2+ chelator. Cyclic stretch-induced cPLA2 activation
and arachidonic acid release was also observed to in-
volve influxes of extracellular Ca2+. Stretch-activated
Ca2+ channels appeared to be involved as Gd3+, a
inhibitor of stretch-activated channels, completely inhib-
ited the cyclic-stretch-induced cPLA2 activation, arachi-
donic acid release, and ERK 1/2 activation. These findings
contrast with reports wherein cyclic stretch induces ERK
1/2 activation via Ca2+ influx independently of stretch-
activated channels as shown in alveolar epithelial cells
[13], but it is in accordance with other tissue studies show-
ing a requirement for stretch-activated channels for cyclic
stretch-induced ERK 1/2 activation [34, 35] In summary,
these data are consistent with the involvement of Ca2+ in
cyclic stretch-induced cPLA2 activation, arachidonic acid
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Fig. 8. Arachidonic acid induces c-Src acti-
vation in time- and dose-dependent manner
in rabbit proximal tubule cells. (A) Serum-
starved proximal tubule epithelial cells were
either exposed to arachidonic acid for the in-
dicated times or (B) various concentrations
of arachidonic acid (0 to 30 lmol/L) for
5 minutes and c-Src was evaluated by Western
blot analysis using an anti- phosphorylated
Src py416-specific antibody (upper panel). The
same blot was stripped and reprobed with con-
trol anti-c-Src antibody showing equal load-
ing and confirming the signal detected with
the phospho-antibody (lower panels). Bar
graphs represent intensities of phospho-c-Src
quantified by scanning densitometry of blots
and are expressed as a percentage relative
to control. Data are mean ± SEM of three
independent experiments. Statistical compar-
isons were made with a one-way analysis of
variance (ANOVA) followed by Newman-
Keuls multiple comparisons test. ∗∗∗P < 0.001;
∗∗P < 0.01; ∗P < 0.05 with respect to control
cells.
release and ERK 1/2 activation in rabbit proximal tubule
cells, implying that cPLA2 may act as a linker between
the Ca2+ signal and ERK 1/2 activation.
Our laboratory has previously shown that arachidonic
acid is critical to angiotensin II-induced phosphorylation
of the EGF receptor and that the tyrosine phosphory-
lated EGF receptor is critical to MAPK activation [36]. In
this model, signaling involves tyrosine phosphorylation of
the EGF receptor, its association with the Shc/Grb2/Sos
complex, activation of the small guanosine triphosphate
(GTP) binding protein p21ras and MAPK (ERK 1/2)
activation[18, 36]. In the present study, we have demon-
strated that cyclic stretch-induced EGF receptor phos-
phorylation and c-Src activation in a time-dependent
manner. Pretreatment with the selective EGF recep-
tor antagonist AG1478 greatly reduced cyclic stretch-
induced ERK 1/2 phosphorylation, but had no effect on
the capacity of cyclic stretch to induce the activation
of c-Src. By analogy, pretreatment with the potent Src
family kinase inhibitor PP2 greatly reduced both cyclic
stretch-induced ERK 1/2 and EGF receptor phospho-
rylation, consistent with c-Src being upstream of these
events. Similar to our studies, utilizing bovine coronary ar-
teries (BCA) demonstrated that passive stretch-induced
ERK 1/2 and EGF receptor phosphorylation were atten-
uated by inhibition of c-Src kinase with PP2 and EGF
receptor kinase with AG1478 [37]. Conversely, stud-
ies employing rabbit aortas demonstrated that pulsatile
stretch-induced activation of ERK 1/2 was also depen-
dent on EGF receptor phosphorylation, but independent
of c-Src [38]. Our findings are significant for they not only
confirm an involvement of both EGF receptor phospho-
rylation and c-Src activation in stretch-induced arachi-
donic acid signaling in proximal tubular epithelial cells
leading to ERK 1/2 activation, but they appear to link
mechanotransduction in renal epithelial cells to the sig-
naling paradigm observed with angiotensin II, suggesting
that an angiotensin II receptor might be linked to stretch-
induced ERK 1/2 activation.
Indeed, angiotensin has been linked to cyclic stretch-
induced MAPK activation. Particularly, cyclic stress of
cardiac myocytes demonstrated angiotensin type 1 (AT1)
receptor-dependent increase in angiotensin II levels
which appear to be linked to modulation of ERK 1/2
activation [39–41], whereas an AT1 receptor-dependent
increase in angiotensin II levels does not appear to be
linked to modulation of JNK activation [42]. Our re-
sults show that neither angiotensin type 1 AT1 (losartan
and candesartan) nor AT2 (PD 123319) receptor antago-
nists had an effect on cyclic stretch-induced arachidonic
acid release or ERK 1/2 activation in rabbit proximal
tubule cells. In addition, our unpublished data show that
when the culture medium conditioned by stretching prox-
imal tubule cells was transferred to unstretched proximal
tubule cells, no significant increase in ERK 1/2 activ-
ity was observed, suggesting that cyclic stretch-induced
arachidonic acid release and ERK 1/2 activation in kidney
epithelium occurs via AT1 and AT2 receptor-independent
signaling pathways.
CONCLUSION
Our findings demonstrate for the first time in re-
nal epithelium that cPLA2 and arachidonic released
by cyclic mechanical stretch is one of the signals that
triggers c-Src activation and EGF receptor and ERK
1/2 phosphorylation in proximal tubular cells. More-
over, EGF receptor phosphorylation appears to mediate
cyclic stretch-induced ERK 1/2 activation via activa-
tion of c-Src in part through Ca2+-dependent signal-
ing via stretch-activated channels in proximal tubular
cells. In contrast to our previous observations wherein
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Fig. 9. Cyclic stretch-induced extracellular-regulated kinases 1 and 2
(ERK 1/2) activation is mediated via epidermal growth factor (EGF)
receptor- and c-Src-dependent pathways. Serum-starved proximal tubu-
lar cells were incubated with or without 500 nmol/L AG1478 or 10
lmol/L PP2 for 60 minutes and then exposed to cyclic stretch (30 cy-
cles/minute; 15% stretch) for 15 minutes. (A) Activation of c-Src was
evaluated by Western blot analysis using an anti-phosphorylated Src
py416-specific antibody (upper panel). (B) EGF receptor was immuno-
precipitated (IP) from protein extracts (1 mg) using a anti-EGF recep-
tor antibody and subsequently evaluated by Western blot analysis using
an anti-phosphorylated EGF receptor py1068-specific antibody (upper
panel). (C) Activation of ERK 1/2 was evaluated by Western blot using
a polyclonal antibody that specifically recognizes the phosphorylated
forms of ERK 1 and ERK 2 (upper panel). The same blot was stripped
and reprobed with control anti-c-Src, anti-EGF receptor or anti-ERK
1/2 antibodies showing equal loading and confirming the signal detected
with the phospho-antibody (lower panels). Bar graphs represent inten-
sities of both phospho-ERK 1 and phosphor-ERK 2, phospho-c-Src,
and phospho-EGF receptor quantified by scanning densitometry of
blots and are expressed as a percentage relative to control. Data are
mean ± SEM of three independent experiments. Statistical comparisons
were made with a one-way analysis of variance (ANOVA) followed by
Newman-Keuls multiple comparisons test. ∗∗∗P < 0.001 (with respect
to unstretched cells); +++P < 0.001 (stretch versus stretch + inhibitor).
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angiotensin II-induced ERK 1/2 activation was linked to
an angiotensin II type 2 (AT2) receptor in these same
kidney epithelial cells, cyclic stretch-induced arachidonic
acid release and ERK 1/2 activation appears to be in-
dependent of this signaling paradigm. Although the link
between the present finding and the pathogenesis and
therapy for hypertensive renal injury remains unclear,
these findings significantly enhances our understanding
of the signaling pathways of mechanotransduction, which
may be involved in the regulation of renal epithelial func-
tion in the proximal tubule cells.
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